Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre De La Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette*

*Corresponding author

Research output: Contribution to journalArticle

Fingerprint

Dive into the research topics of 'Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science